Evaluation of intranasal delivery route of drug administration for brain targeting
- PMID: 30449731
- DOI: 10.1016/j.brainresbull.2018.10.009
Evaluation of intranasal delivery route of drug administration for brain targeting
Abstract
The acute or chronic drug treatments for different neurodegenerative and psychiatric disorders are challenging from several aspects. The low bioavailability and limited brain exposure of oral drugs, the rapid metabolism, elimination, the unwanted side effects and also the high dose to be added mean both inconvenience for the patients and high costs for the patients, their family and the society. The reason of low brain penetration of the compounds is that they have to overcome the blood-brain barrier which protects the brain against xenobiotics. Intranasal drug administration is one of the promising options to bypass blood-brain barrier, to reduce the systemic adverse effects of the drugs and to lower the doses to be administered. Furthermore, the drugs administered using nasal route have usually higher bioavailability, less side effects and result in higher brain exposure at similar dosage than the oral drugs. In this review the focus is on giving an overview on the anatomical and cellular structure of nasal cavity and absorption surface. It presents some possibilities to enhance the drug penetration through the nasal barrier and summarizes some in vitro, ex vivo and in vivo technologies to test the drug delivery across the nasal epithelium into the brain. Finally, the authors give a critical evaluation of the nasal route of administration showing its main advantages and limitations of this delivery route for CNS drug targeting.
Keywords: CNS indication; Delivery enhancer techniques; Drug delivery; Intranasal administration; Transporter interactions.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.Pharm Nanotechnol. 2017;5(3):203-214. doi: 10.2174/2211738505666170515113936. Pharm Nanotechnol. 2017. PMID: 28521670 Review.
-
Intranasal drug delivery to the central nervous system: present status and future outlook.Curr Pharm Des. 2013;19(3):510-26. Curr Pharm Des. 2013. PMID: 23116337 Review.
-
Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.Curr Drug Deliv. 2019;16(10):887-901. doi: 10.2174/1567201816666191029122740. Curr Drug Deliv. 2019. PMID: 31660815 Review.
-
Potential of nanoparticulate drug delivery systems by intranasal administration.Curr Pharm Des. 2010 May;16(14):1644-53. doi: 10.2174/138161210791164108. Curr Pharm Des. 2010. PMID: 20210751 Review.
-
Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier.J Drug Target. 2002 Jun;10(4):285-96. doi: 10.1080/713714452. J Drug Target. 2002. PMID: 12164377 Review.
Cited by
-
An Overview on the Physiopathology of the Blood-Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery.Pharmaceutics. 2024 Jun 22;16(7):849. doi: 10.3390/pharmaceutics16070849. Pharmaceutics. 2024. PMID: 39065547 Free PMC article. Review.
-
Intranasal Therapy in Palliative Care.Pharmaceutics. 2024 Apr 9;16(4):519. doi: 10.3390/pharmaceutics16040519. Pharmaceutics. 2024. PMID: 38675179 Free PMC article. Review.
-
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport.Pharmaceutics. 2024 Apr 1;16(4):481. doi: 10.3390/pharmaceutics16040481. Pharmaceutics. 2024. PMID: 38675142 Free PMC article. Review.
-
Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases.Pharmaceutics. 2024 Mar 1;16(3):350. doi: 10.3390/pharmaceutics16030350. Pharmaceutics. 2024. PMID: 38543244 Free PMC article. Review.
-
UDP-Glucose/P2Y14 Receptor Signaling Exacerbates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats.Stroke. 2024 May;55(5):1381-1392. doi: 10.1161/STROKEAHA.123.044422. Epub 2024 Mar 25. Stroke. 2024. PMID: 38525592
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources